NASDAQ: MURA - Mural Oncology plc

Yield per half year: +16.77%
Dividend yield: 0.00%

Share chart Mural Oncology plc

Extended chart Simple chart
Financial Markets by TradingView

About Mural Oncology plc

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs.

more details
Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2023-11-16
ISIN IE000LK2BOB4
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.muraloncology.com
Цена ао 3.66
Change price per day: 0% (3.9)
Change price per week: +7.44% (3.63)
Change price per month: -8.45% (4.26)
Change price per 3 month: +13.37% (3.44)
Change price per half year: +16.77% (3.34)
Change price per year: -17.89% (4.75)
Change price per 3 year: 0% (3.9)
Change price per 5 year: 0% (3.9)
Change price per 10 year: 0% (3.9)
Change price per year to date: +18.54% (3.29)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.3745 10
P/E 0 0
EV/EBITDA 0.8176 10
Total: 5

Efficiency

Title Value Grade
ROA, % -68.75 0
ROE, % -78.63 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0781 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 10.82 2
Yield EPS, % 18.26 3
Total: 2.4
More

Institutions Volume Share, %
Westfield Capital Management Co LP 1985886 11.9
Bank Of New York Mellon Corporation 399462 2.39
PRIMECAP Management Company 256255 1.54
Dimensional Fund Advisors LP 238482 1.43
HRT Financial LP 201934 1.21
Artisan Partners Limited Partnership 185432 1.11
Norges Bank Investment Management 168511 1.01
Charles Schwab Investment Management, Inc. 81208 0.49
PanAgora Asset Management, Inc. 63924 0.38
Connor Clark & Lunn Investment Management Ltd 51162 0.31

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Micro-Cap ETF 0.0142 17.09 1.54048
Schwab 1000 Index ETF 0.0001 25.15 1.42441
0.0121.121.48

Head Job title Payment Year of birth
Ms. Caroline J. Loew Ph.D. President, CEO & Director 303.29k 1971 (54 years)
Mr. Adam D. Cutler B.A. CFO, Principal Financial Officer & Principal Accounting Officer 496.65k 1975 (50 years)
Ms. Maiken Keson-Brookes Chief Legal Officer N/A 1973 (52 years)
Mr. Justin Levine Head of Human Resources & VP of Human Resources N/A
Dr. Vicki L. Goodman M.D. Chief Medical Officer 578.34k 1971 (54 years)

Address: Ireland, Dublin D T, 10 Earlsfort Terrace - open in Google maps, open in Yandex maps
Website: https://www.muraloncology.com